OR WAIT null SECS
November 03, 2020
Biological and analytical advances enable modern fermentation processes to deliver safe and effective next-generation medicines.
October 16, 2020
The new VirusExpress lentiviral production platform increases dose yields and reduces process development time for cell and gene therapies.
October 03, 2020
The manufacture of gene therapy vectors is shifting to more modern technologies.
September 14, 2020
The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
June 01, 2020
The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.
November 06, 2019
The company will invest $24 million into its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell-culture media.
September 01, 2019
The evolution of cell-culture technology is driving the need for improvements in modeling solutions.
August 29, 2019
A new defined coated cell cultureware by denovoMATRIX allow for the serum-free expansion of mesenchymal stem cells.
August 28, 2019
The partners will collaborate to identify the bioactive components in hydrolysates, which have long been used as additives in cell culture media and feed formulation in the biopharma industry.